{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:31:19Z","timestamp":1761975079090},"reference-count":12,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T00:00:00Z","timestamp":1238371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>H<jats:sub>1<\/jats:sub>\u2010antihistamines are widely used in the treatment of various allergic diseases. Particularly, a cornerstone of the management of chronic idiopathic urticaria is treatment with H<jats:sub>1<\/jats:sub>\u2010antihistamines. However, a few cases of H<jats:sub>1<\/jats:sub>\u2010antihistamine\u2010induced urticaria have been reported. A 34\u2010year\u2010old woman presented with a 4\u2010month history of recurrent urticaria, which was prominently exacerbated by the administration of H<jats:sub>1<\/jats:sub>\u2010antihistamines. The patient consented to a provocation test of fexofenadine among drugs including cetirizine and hydroxyzine, which were suspected of inducing severe symptoms in episodes. One hour after challenge with 12\u00a0mg fexofenadine (one\u2010fifth of the therapeutic dose), a urticarial reaction rapidly developed on nearly the entire body with remarkably increased levels of plasma histamine (190\u00a0nmol\/L) and plasma leukotriene B4 (150\u00a0pg\/mL). In challenge tests with other antihistamines, generalized urticaria occurred 5 and 1\u00a0h after intake of 10\u00a0mg loratadine and 10\u00a0mg bepotastine, respectively, whereas challenges with chlorpheniramine, mequitazine and azelastine were all negative. Skin prick tests with H<jats:sub>1<\/jats:sub>\u2010antihistamines used in the challenges were all negative, indicating that the urticarial reactions after challenges with the causative drugs might not be immunoglobulin E\u2010mediated. Among the causative drugs in our case, cetirizine and hydroxyzine are the piperazine derivatives, whereas fexofenadine, bepotastine, ebastine and loratadine are the piperidine derivatives. The chemical structures of both derivatives are very similar. Therefore, in this case, H<jats:sub>1<\/jats:sub>\u2010antihistamine\u2010induced urticaria may have been due to cross\u2010reactivity between metabolites of these drugs, but not to drugs before metabolization. Hypersensitivity to H<jats:sub>1<\/jats:sub>\u2010antihistamines should be considered when urticarial lesions worsen after H<jats:sub>1<\/jats:sub>\u2010antihistamine treatment.<\/jats:p>","DOI":"10.1111\/j.1346-8138.2009.00627.x","type":"journal-article","created":{"date-parts":[[2009,3,31]],"date-time":"2009-03-31T08:09:46Z","timestamp":1238486986000},"page":"224-227","source":"Crossref","is-referenced-by-count":17,"title":["Multiple H<sub>1<\/sub>\u2010antihistamine\u2010induced urticaria"],"prefix":"10.1111","volume":"36","author":[{"given":"Naoko","family":"INOMATA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoko","family":"TATEWAKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenro","family":"IKEZAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,3,30]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2000.00651.x"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.11.048"},{"issue":"10","key":"e_1_2_4_4_2","first-page":"22","article-title":"Skin tests used in type I allergy testing. Position paper","volume":"44","author":"Dreborg S.","year":"1989","journal-title":"Allergy"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.1949.22"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1998.tb03982.x"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02849.x"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2001.03980.x"},{"key":"e_1_2_4_9_2","first-page":"136","article-title":"Urticaria to cetirizine","volume":"12","author":"Tella R","year":"2002","journal-title":"J Investig Allergol Clin Immunol"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2002.00988.x"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000083795"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1993.tb02412.x"},{"key":"e_1_2_4_13_2","first-page":"170","article-title":"Anaphylactic reaction to ranitidine and dexchlorpheniramine","volume":"17","author":"Thurot\u2010Guillou C","year":"2007","journal-title":"Eur J Dermatol"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1346-8138.2009.00627.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1346-8138.2009.00627.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T05:19:31Z","timestamp":1697174371000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1346-8138.2009.00627.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,30]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1111\/j.1346-8138.2009.00627.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1346-8138.2009.00627.x","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,30]]}}}